Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.

ABSTRACT:

SUBMITTER: Pattanaik S 

PROVIDER: S-EPMC6517182 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature